Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Publication of GT200400141ApublicationCriticalpatent/GT200400141A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE PIRAZOLO[4,3D]PIRIMIDINA Y PIRAZOLO[3,4D]PIRIDINA COMO LIGANDOS DE LOS RECEPTORES DE CANABINOIDES, EN PARTICULAR ANTAGONISTAS DEL RECEPTOR CB1 Y SUS USOS PARA TRATAR ENFERMEDADES, AFECCIONES Y/O TRASTORNOS MODULADOS POR ANTAGONISTAS DE RECEPTORES DE CANABINOIDES.THE PRESENT INVENTION REFERS TO PIRAZOLO [4,3D] PIRIMIDINE AND PIRAZOLO [3,4D] PIRIDINE COMPOUNDS AS LIGANDOS OF THE CANABINOID RECEPTORS, IN PARTICULAR ANTAGONISTS OF THE CB1 RECEPTOR AND ITS USES TO TREAT DISEASES OR DISORDERS / DISORDERS BY ANABOGONISTS OF CANABINOID RECEPTORS.
GT200400141A2004-01-292004-07-22
LINES OF CANABINOID RECEPTORS AND THEIR USES.
GT200400141A
(en)
COMPOUNDS DERIVED FROM PIRAZOLOTRIAZINA; AND PHARMACEUTICAL COMPOSITION USEFUL TO TREAT DISEASES AND / OR DISORDERS MODULATED BY CANABINOID RECEPTOR ANTAGONISTS, AS OBESITY.